Disseminated infection with mycobacterium avium complex in patients with HIV-infection;Die disseminierte infektion mit mycobacterium avium complex (MAC) bei HIV-infektion

Medizinische Klinik

Volumn 93, Issue 6, 1998, Pages 360-364

  Fätkenheuer, Gerd ^a,b   Salzberger, Bernd ^a   Diehl, Volker ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

AIDS; HIV Infection; Mycobacterium avium complex

Indexed keywords

AMIKACIN; AZITHROMYCIN; CLARITHROMYCIN; ETHAMBUTOL; RIFABUTIN;

BONE MARROW CULTURE; CLINICAL FEATURE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LEUKOPENIA; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; REVIEW; SIDE EFFECT; SPUTUM CULTURE; UVEITIS;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0032526063     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044680     Document Type: Review

References (41)

1. Benson, C.: Disseminated mycobacterium avium complex disease in patients with AIDS. AIDS Res. hum Retroviruses 10 (1994), 913-916.
2. Benson, C. A.: Disease due to the mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin. infect. Dis. 18 (1994), S218-222
3. Cappell, M. S., M. S. Schwartz, L Biempica: Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Amer. J. Med. 88 (1990), 123-130.
4. Cato, A., J. H. Cavanaugh, H. Shi, A. Hsu, G. G. R., J. Leonard: Assessment of multiple doses of ritonavir on the pharmacokinetics of rifabutin. XI. International Conference on AIDS, Vancouver, July 7-12, 1996.
5. Cavicchi, M., G. Pialoux, F. Carnot, C. Offredo, C. Romana, P. Deslandes, B. Dupont, P. Berthelot, S. Pol; Value ofliver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase. Clin. infect. Dis. 20 (1995), 606-610.
6. Chaisson, R. E., C. A. Benson, M P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R., Sattler Clarithromycin therapy for bacteremic mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team Ann. intern. Med. 121 (1994), 905-911.
7. Cohn, D. L , C. A. Benson, P Williams, T. Nevin, J. Korvick, R Hafner, D. Bourland, E. Kopek, S. Becker, P. Hojczyk, P. Timmons, C. Child: A prospective, randomised, double-blind, comparative study of the safety and efficacy of clarithromycin versus rifabutin versus the combination for the prevention of mycobacterium avium complex bacteremia or disseminated MAC disease. XI. International Conference on AIDS, Vancouver, July 7-12, 1996.
8. Cohn, D. L., E. Fisher, B. Franchino. J. Hodges, J. Chesnut, C. Child, C. Gilbert, W. El-Sadr, R. Hafner, M. Ropka, L. Heifets. J. Clotfelter, D. Munroe, R. Caldwell, K. Canady, C. Horsburgh: Comparison of two doses of clarithromycin in a randomized trial of four 3-drug regimens for treatment of disseminated mycobacterium avium. complex disease in AIDS: excess mortality associated with high-dose clarithromycin. XI. International Conference on AIDS, Vancouver, July 7-12, 1996.
9. Gray, J. R., L. Rabeneck: Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Amer. J Gastroenterol. 84 (1989), 1521-1524.
10. Havlir, D , F. Torriani, M. Dube: Uveitis associated with rifabutin prophylaxis. Ann intern Med. 121 (1994), 510-512.
11. Havlir, D V., M. P. Dube, F. R. Sattler, D. N Forthal, C. A. Kemper, M. W. Dunne, D. M. Parenti, J. P. Lavelle, A. C. White Jr, M D Witt, S. A. Bozzette, J. A. McCutchan Prophylaxis against disseminated mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. New Engl. J. Med. 335 (1996), 392-398.
12. Hawkins, C. C., J. W. Gold, E. Whimbey, T. E. Kiehn, P. Brannon, R. Cammarata, A. E Brown, D. Armstrong: Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann. intern, Med. 105 (1986), 184-188.
13. Horsburgh, C. R Jr: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New Engl. J. Med. 324 (1991), 1332-1338.
14. Horsburgh, C. R. Jr, J. A. Havlik, D A Ellis, E. Kennedy, S. A. Fann, R. E. Dubois, S E Thompson: Survival of patients with acquired immune deficiency syndrome and disseminated mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Amer. Rev. resp. Dis. 144 (1991), 557-559
15. Horsburgh, C. R. Jr, B. Metchock, S. M. Gordon, J. A. Havlik Jr, J. E. McGowan Jr, S. E. R. Thompson: Predictors of survival in patients with AIDS and disseminated mycobacterium avium complex disease. J. infect. Dis. 170 (1994), 573-577.
16. Horsburgh, C. R. Jr, B. G. Metchock, J. E. McGowan Jr, S. E. Thompson: Clinical implications of recovery of mycobacterium avium complex from the stool or respiratory tract of HIV-infected individuals [letter]. Aids 6 (1992), 512-514.
17. Ives, D. V., R. B. Davis, J. S. Currier: Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated mycobacterium avium complex. Aids 9 (1995), 261-266.
18. Jacobson, M. A., P. C. Hopewell, D. M. Yajko, W. K. Hadley, E. Lazarus, P. K. Mohanty, G. W. Modin, D. W. Feigal, P. S. Cusick, M. A. Sande: Natural history of disseminated mycobacterium avium complex infection in AIDS. J. infect. Dis. 164 (1991), 994-998.
19. Katz, M. H., N. A. Hessol, S. P. Buchbinder, A. Hirozawa, P O'Malley, S. D. Holmberg: Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J. infect. Dis. 170 (1994), 198-202.
20. Kemper, C. A., S. C. Deresinski: Mycobacterium avium complex infection in AIDS. AIDS clin. Rev. 96 (1995), 153-228.
21. Koch-Institut, R.: AIDS/HIV Quartalsbericht IV/96, 1996
22. Modilevsky, T., F R. Sattler, P. F. Barnes: Mycobacterial disease inpatients with human immunodeficiency virus infection. Arch. intern. Med. 149 (1989), 2201-2205.
23. Moore, R. D., R. E. Chaisson: Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann. intern. Med. 124 (1996), 633-642.
24. Moore, R. D., R. E. Chaisson: Survival analysis of two controlled trials of rifaburin prophylaxis against mycobactenum avium complex in AIDS. Aids 9 (1995), 1337-1342.
25. Narang, P. K., C. B. Trapnell, J. R. Schoenfelder, J. P. Lavelle, J. R. Bianchine: Fluconazole and enhanced effect of rifaburin prophylaxis [letter; comment]. New Engl. J. Med. 330 (1994), 1316-1317.
26. Nightingale, S. D.: Rifabutin prophylaxis against mycobacterium avium complex infection [letter; comment]. Lancet 345 (1995), 265.
27. Nightingale, S. D., L. T. Byrd, P. M. Southern, J. D. Jockusch, S. X. Cal, B. A. Wynne: Incidence of mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J. infect. Dis. 165 (1992), 1082-1085.
28. Northfelt, D. W., A. Mayer, L. D. Kaplan, D. I. Abrams, W K. Hadley, D. M. Yajko, B. G. Herndier: The usefulness of diagnostic bone marrow examination in patients with human immunodeficiency virus (HIV) infection. J. acquir. Immun. Def. Syndr. 4 (1991), 659-666.
29. Peters, M., C Muller, S. Rusch-Gerdes, C. Seidel, U. Gobel, H. D Pohle, B. Ruf: Isolation of atypical mycobacteria from tap water in hospitals and homes: is this 2 possible source of disseminated MAC infection in AIDS patients? J. Infect. 31 (1995), 39-44.
30. Pierce, M., S. Crampton, D. Henry, L. Heifets, A. La Marca, M. Montecalvo, G. P. Wormser, H. Jablonowski, J Jemsek, M. Cynamon, B. G. Yangco, G. Notario, J. C. Craft: A randomized trial of clarithromycin as prophylaxis against disseminated mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. New Engl. J. Med. 335 (1996), 384-391.
31. Roger, P. M., V Mondain, M. C. Saint Paul, M. Carles, B. Taillan, J. G. Fuzibet, J F Michiels, P. Dujardin, P. Dellamonica: Liver biopsy is not useful in the diagnosis of mycobacterial infections in patients who are infected with human immunodeficiency virus. Clin. infect. Dis. 23 (1996), 1302-1304.
32. Rubin, D. S., J. J. Rahal: Mycobacterium-avium complex. Infect. Dis. Clin. N. Amer. 8 (1994), 413-426.
33. Shafran, S. D., J. Singer, D. P. Zarowny, P. Phillips, I. Salit, S. L. Walmsley, I. W. Fong, M. J. Gill, A. R. Rachlis, R G. Lalonde, M. M. Fanning, C. M. Tsoukas: A comparison of two regimens for the treatment of mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. New Engl. J. Med. 335 (1996), 377-383.
34. Sison, J. P., Y. Yao, C. A. Kemper, J. R. Hamilton, E. Brummer, D. A. Stevens, S C. Deresinski: Treatment of mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J. infect. Dis. 173 (1996), 677-683.
35. Sullam, P. M., F. M. Gordin, B. A. Wynne: Efficacy of rifabutin in the treatment of disseminated infection due to mycobacterium avium complex. The Rifabutin Treatment Group. Clin. infect. Dis. 19 (1994), 84-86.
36. The Indinavir (MK. 639) Pharmacokinetic Study Group, M. R. L., Jefferson Med. Coll. (US), SUNY Stony Brook (US), Robert Wood Johnson Med. School (US), St. Pierre Univ. Hospital (BEL): Indinavir (MK 639) Drug Interaction Studies. XI. International Conference on AIDS, Vancouver, July 7-12, 1996.
37. Uribe-Botero, G., J. G. Prichard, H. J. Kaplowitz: Bone marrow in HIV infection. A comparison of fluorescent staining and cultures in the detection of mycobacteria. Amer J. clin. Pathol. 91 (1989), 313-315.
38. USPHS/IDSA: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Morb. Mortal wkly. Rep. 44 (1995), 1-34.
39. Wallace, J. M., J. B. Hannah: Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest 93 (1988), 926-932.
40. Wallace, R. J. Jr, B. A. Brown, D. E. Griffith, W. Girard, K. Tanaka: Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for mycobacterium avium-m. intracellulare infection. J. infect. Dis. 171 (1995), 747-750.
41. Yajko, D. M., D. P. Chin, P. C. Gonzalez, P. S. Nassos, P. C. Hopewell, A. L. Reingold, C. R. Horsburgh Jr, M. A. Yakrus, S. M. Ostroff, W. K. Hadley: Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J. acquir. Immun. Def. Syndr. hum. Retrovirol. 9 (1995), 176-182.